Balance Sheet Details

12 Months Ended

Dec. 31, 2024

Balance Sheet Details

Balance Sheet Details

6. Balance Sheet Details

Property and Equipment, net

Property and equipment as of December 31, 2024 and 2023 consisted of the following (in thousands):

	December 31, 2024		December 31, 2023
Laboratory equipment	$	21,316	$	19,678
Furniture and fixtures		831		817
Office and computer equipment		438		438
Leasehold improvements		3,802		3,447
Total		26,387		24,380
Less: accumulated depreciation		(13,146)		(11,821)
Property and equipment, net	$	13,241	$	12,559

Depreciation and amortization expense totaled $1.3 million and $1.0 million for the years ended December 31, 2024 and 2023, respectively. Property and equipment not in use was $8.3 million and $8.1 million as of December 31, 2024 and 2023, respectively, and is included in the laboratory equipment in the table above. These assets are not depreciated until they are placed in service.

Other Receivables

Other receivables as of December 31, 2024 and 2023 consisted of the following (in thousands):

	December 31, 2024		December 31, 2023
Tenant improvement allowance receivable (Note 12)	$	—	$	1,835
Grant and award receivable (Note 13)		744		1,528
	$	744	$	3,363

Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities as of December 31, 2024 and 2023 consisted of the following (in thousands):

	December 31, 2024		December 31, 2023
Accounts payable	$	766	$	1,585
Accrued clinical trial expenses		828		3,021
Other accrued expenses		461		1,083
	$	2,055	$	5,689